China Covid-19 vaccine dose over 95% effective vs ICU admission

China Covid-19 vaccine dose over 95% effective vs ICU admission – study

By Global Times

Jun 12, 2022 12:23 am

CONVIDECIA, a vaccine produced by Chinese manufacturer CanSino Biologics, showed a 95.35-percent efficacy rate in preventing intensive care unit admission 28 days after one shot in administrated to a person, a study conducted in Chile found.

The efficacy was similar to the 96.56-percent rate for two doses of Pfizer's mRNA vaccine after 14 days and higher than the 86.88-percent rate of two shots of inactivated vaccines after two weeks, according to a statement released by the company on Monday.

This July 12, 2021 file photo shows a medical worker preparing a dose of a Covid-19 vaccine at a vaccination site in Quito, Ecuador. XINHUA PHOTO

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Pope still improving, Vatican eyes end of hospitalization

Search ends for missing crew member after North Sea collision

Majority of the world's population breathes dirty air – report

Musk says X hit by major cyberattack

Massive Fukushima plant cleanup exposes workers to high radiation and stress

120,000 properties still blacked out in storm-hit Australia

NKorea fires missiles amid US-SKorea drills